HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoming Zhang Selected Research

Xylose (D-Xylose)

12/2021Accelerated Dissipation of Free and Immobilized Water Facilitating the Intramolecular Dehydration of N-Xylosamine and Conversion Improvement of the Amadori Rearrangement Product of Aspartic Acid-Xylose Reaction.
9/2020Transformation between 2-Threityl-thiazolidine-4-carboxylic Acid and Xylose-Cysteine Amadori Rearrangement Product Regulated by pH Adjustment during High-Temperature Instantaneous Dehydration.
8/2019N-(1-Deoxy-d-xylulos-1-yl)-glutathione: A Maillard Reaction Intermediate Predominating in Aqueous Glutathione-Xylose Systems by Simultaneous Dehydration-Reaction.
9/2018Synergistic Effect of a Thermal Reaction and Vacuum Dehydration on Improving Xylose-Phenylalanine Conversion to N-(1-Deoxy-d-xylulos-1-yl)-phenylalanine during an Aqueous Maillard Reaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoming Zhang Research Topics

Disease

49Neoplasms (Cancer)
10/2022 - 08/2004
23Inflammation (Inflammations)
01/2022 - 05/2007
14Chronic Renal Insufficiency
04/2022 - 07/2012
13Infections
07/2022 - 02/2009
9Breast Neoplasms (Breast Cancer)
09/2022 - 12/2009
9Fibrosis (Cirrhosis)
11/2021 - 08/2010
8Neoplasm Metastasis (Metastasis)
10/2022 - 01/2013
7Dehydration (Water Stress)
07/2022 - 09/2018
7Heart Failure
01/2022 - 07/2014
7Glioma (Gliomas)
10/2021 - 08/2004
7Spinal Cord Injuries (Spinal Cord Injury)
11/2017 - 06/2009
6Carcinoma (Carcinomatosis)
04/2022 - 10/2012
6Insulin Resistance
05/2017 - 09/2010
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2014
5Aortic Dissection
01/2022 - 05/2009
5Thoracic Aortic Aneurysm
01/2022 - 08/2015
5Carcinogenesis
10/2021 - 01/2019
5Cognitive Dysfunction
04/2020 - 08/2007
5Hyperglycemia
01/2020 - 01/2013
5Atherosclerosis
11/2015 - 07/2012
4Communicable Diseases (Infectious Diseases)
07/2022 - 03/2011
4Hypertension (High Blood Pressure)
06/2022 - 07/2012
4Chronic Kidney Failure (Chronic Renal Failure)
07/2020 - 07/2014
4Albuminuria
02/2020 - 08/2015
4Hypoxia (Hypoxemia)
12/2019 - 01/2016
4Proteinuria
01/2019 - 02/2014
3Melanoma (Melanoma, Malignant)
09/2022 - 01/2005
3Endometrioid Carcinoma
02/2022 - 11/2013
3Renal Insufficiency (Renal Failure)
01/2022 - 01/2019
3COVID-19
10/2021 - 01/2020
3Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2021 - 08/2010
3Fatigue
04/2021 - 12/2019
3Anemia
07/2020 - 02/2014
3Autoimmune Diseases (Autoimmune Disease)
11/2019 - 04/2013
3Peripheral Arterial Disease
05/2019 - 11/2015
3Body Weight (Weight, Body)
12/2018 - 01/2008
3Myocardial Infarction
05/2017 - 01/2015
3Coronary Disease (Coronary Heart Disease)
09/2016 - 11/2015
3Type 2 Diabetes Mellitus (MODY)
11/2015 - 05/2015
3Thoracic Aorta Dissection
08/2015 - 05/2009

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2003
15Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2014
11RNA (Ribonucleic Acid)IBA
06/2022 - 02/2010
9MicroRNAs (MicroRNA)IBA
06/2022 - 01/2011
9LipopolysaccharidesIBA
08/2021 - 01/2013
8Pharmaceutical PreparationsIBA
01/2021 - 12/2014
7Messenger RNA (mRNA)IBA
06/2022 - 03/2003
7Long Noncoding RNAIBA
06/2022 - 01/2019
7Biological ProductsIBA
05/2022 - 09/2003
7VaccinesIBA
10/2021 - 02/2009
6AntigensIBA
09/2022 - 11/2010
6CytokinesIBA
01/2020 - 07/2012
5Competitive Endogenous RNAIBA
06/2022 - 01/2020
5CreatinineIBA
01/2022 - 01/2016
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2013
5Oxygen (Dioxygen)IBA
07/2020 - 11/2014
5C-Reactive ProteinIBA
01/2020 - 07/2012
41,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2022 - 01/2019
4Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2009
4Xylose (D-Xylose)FDA Link
12/2021 - 09/2018
4Hemoglobins (Hemoglobin)IBA
07/2020 - 01/2017
4InterferonsIBA
01/2020 - 05/2007
4Triglycerides (Triacylglycerol)IBA
12/2018 - 01/2013
4Interleukin-6 (Interleukin 6)IBA
05/2017 - 01/2013
4Matrix Metalloproteinases (MMPs)IBA
06/2014 - 05/2009
4Toll-Like Receptor 4IBA
11/2013 - 12/2011
4Streptozocin (Streptozotocin)FDA Link
01/2013 - 08/2007
3EnzymesIBA
07/2022 - 12/2019
3AntioxidantsIBA
07/2022 - 04/2016
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 01/2021
3Circular RNAIBA
06/2022 - 01/2020
3Phenylalanine (L-Phenylalanine)FDA Link
11/2021 - 01/2018
3Transforming Growth Factor beta (TGF-beta)IBA
11/2021 - 06/2009
3Sirtuin 1IBA
08/2021 - 01/2013
3ElementsIBA
04/2021 - 01/2019
3Bleomycin (Blenoxane)FDA LinkGeneric
04/2021 - 08/2010
3Immunoglobulin G (IgG)IBA
11/2020 - 01/2015
3AcidsIBA
09/2020 - 07/2012
3Anti-Bacterial Agents (Antibiotics)IBA
06/2020 - 01/2018
3ProdrugsIBA
06/2020 - 01/2018
3Phosphates (Orthophosphate)IBA
01/2020 - 07/2012
3Fibroblast Growth Factor-23IBA
01/2020 - 07/2012
3Sirolimus (Rapamycin)FDA Link
01/2019 - 01/2019
3Lysine (L-Lysine)FDA Link
03/2017 - 01/2014
3Interleukin-10 (Interleukin 10)IBA
01/2017 - 05/2007
3Nonesterified Fatty Acids (NEFA)IBA
11/2015 - 09/2010
2IntegrinsIBA
10/2022 - 01/2019
2Peptides (Polypeptides)IBA
09/2022 - 04/2005
2AntibodiesIBA
09/2022 - 11/2020

Therapy/Procedure

27Therapeutics
10/2022 - 02/2010
6Stents
01/2022 - 11/2015
5Immunotherapy
09/2022 - 04/2011
5Drug Therapy (Chemotherapy)
01/2022 - 01/2013
3Endovascular Aneurysm Repair
10/2022 - 07/2016
3Photochemotherapy (Photodynamic Therapy)
06/2022 - 12/2014
3Length of Stay
01/2020 - 02/2016
3Catheters
08/2019 - 08/2012
3Kidney Transplantation
02/2019 - 01/2012
3Laparotomy
01/2019 - 08/2012
3Lasers (Laser)
03/2016 - 12/2014